Literature DB >> 15640220

Isolation of llama antibody fragments for prevention of dandruff by phage display in shampoo.

Edward Dolk1, Marcel van der Vaart, David Lutje Hulsik, Gert Vriend, Hans de Haard, Silvia Spinelli, Christian Cambillau, Leon Frenken, Theo Verrips.   

Abstract

As part of research exploring the feasibility of using antibody fragments to inhibit the growth of organisms implicated in dandruff, we isolated antibody fragments that bind to a cell surface protein of Malassezia furfur in the presence of shampoo. We found that phage display of llama single-domain antibody fragments (VHHs) can be extended to very harsh conditions, such as the presence of shampoo containing nonionic and anionic surfactants. We selected several VHHs that bind to the cell wall protein Malf1 of M. furfur, a fungus implicated in causing dandruff. In addition to high stability in the presence of shampoo, these VHHs are also stable under other denaturing conditions, such as high urea concentrations. Many of the stable VHHs were found to contain arginine at position 44. Replacement of the native amino acid at position 44 with arginine in the most stable VHH that lacked this arginine resulted in a dramatic further increase in the stability. The combination of the unique properties of VHHs together with applied phage display and protein engineering is a powerful method for obtaining highly stable VHHs that can be used in a wide range of applications.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15640220      PMCID: PMC544197          DOI: 10.1128/AEM.71.1.442-450.2005

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  35 in total

Review 1.  Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains.

Authors:  S Muyldermans; C Cambillau; L Wyns
Journal:  Trends Biochem Sci       Date:  2001-04       Impact factor: 13.807

2.  Antigen specificity and high affinity binding provided by one single loop of a camel single-domain antibody.

Authors:  A Desmyter; K Decanniere; S Muyldermans; L Wyns
Journal:  J Biol Chem       Date:  2001-05-07       Impact factor: 5.157

3.  A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme.

Authors:  Mireille Dumoulin; Alexander M Last; Aline Desmyter; Klaas Decanniere; Denis Canet; Göran Larsson; Andrew Spencer; David B Archer; Jurgen Sasse; Serge Muyldermans; Lode Wyns; Christina Redfield; André Matagne; Carol V Robinson; Christopher M Dobson
Journal:  Nature       Date:  2003-08-14       Impact factor: 49.962

4.  Preventing phage lysis of Lactococcus lactis in cheese production using a neutralizing heavy-chain antibody fragment from llama.

Authors:  A M Ledeboer; S Bezemer; J J W de Hiaard; I M Schaffers; C T Verrips; C van Vliet; E M Düsterhöft; P Zoon; S Moineau; L G J Frenken
Journal:  J Dairy Sci       Date:  2002-06       Impact factor: 4.034

5.  Isolation of antigen specific llama VHH antibody fragments and their high level secretion by Saccharomyces cerevisiae.

Authors:  L G Frenken; R H van der Linden; P W Hermans; J W Bos; R C Ruuls; B de Geus; C T Verrips
Journal:  J Biotechnol       Date:  2000-02-28       Impact factor: 3.307

6.  Effect of ketoconazole 1% and 2% shampoos on severe dandruff and seborrhoeic dermatitis: clinical, squamometric and mycological assessments.

Authors:  C Piérard-Franchimont; G E Piérard; J E Arrese; P De Doncker
Journal:  Dermatology       Date:  2001       Impact factor: 5.366

Review 7.  Single domain camel antibodies: current status.

Authors:  S Muyldermans
Journal:  J Biotechnol       Date:  2001-06       Impact factor: 3.307

8.  Thermal unfolding of a llama antibody fragment: a two-state reversible process.

Authors:  J M Pérez; J G Renisio; J J Prompers; C J van Platerink; C Cambillau; H Darbon; L G Frenken
Journal:  Biochemistry       Date:  2001-01-09       Impact factor: 3.162

9.  The hair strand test - a new method for testing antifungal effects of antidandruff preparations.

Authors:  Peter Mayser; Horst Argembeaux; Frank Rippke
Journal:  J Cosmet Sci       Date:  2003 May-Jun       Impact factor: 0.948

10.  Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies.

Authors:  R H van der Linden; L G Frenken; B de Geus; M M Harmsen; R C Ruuls; W Stok; L de Ron; S Wilson; P Davis; C T Verrips
Journal:  Biochim Biophys Acta       Date:  1999-04-12
View more
  34 in total

1.  High-level expression of Camelid nanobodies in Nicotiana benthamiana.

Authors:  Yi-Hui Audrey Teh; Tony A Kavanagh
Journal:  Transgenic Res       Date:  2009-10-28       Impact factor: 2.788

Review 2.  Bispecific antibodies in cancer immunotherapy.

Authors:  Siqi Chen; Jing Li; Qing Li; Zhong Wang
Journal:  Hum Vaccin Immunother       Date:  2016-06-01       Impact factor: 3.452

3.  Neutralizing nanobodies targeting diverse chemokines effectively inhibit chemokine function.

Authors:  Christophe Blanchetot; Dennis Verzijl; Azra Mujić-Delić; Leontien Bosch; Louise Rem; Rob Leurs; C Theo Verrips; Michael Saunders; Hans de Haard; Martine J Smit
Journal:  J Biol Chem       Date:  2013-07-08       Impact factor: 5.157

4.  Llama single-chain antibody that blocks lipopolysaccharide binding and signaling: prospects for therapeutic applications.

Authors:  Mohamed El Khattabi; Hendrik Adams; Erik Heezius; Pim Hermans; Frank Detmers; Bram Maassen; Peter van der Ley; Jan Tommassen; Theo Verrips; Jord Stam
Journal:  Clin Vaccine Immunol       Date:  2006-08-23

5.  Crystal structure of the N-terminal domain of the secretin GspD from ETEC determined with the assistance of a nanobody.

Authors:  Konstantin V Korotkov; Els Pardon; Jan Steyaert; Wim G J Hol
Journal:  Structure       Date:  2009-02-13       Impact factor: 5.006

6.  Nanobody-aided structure determination of the EpsI:EpsJ pseudopilin heterodimer from Vibrio vulnificus.

Authors:  Anita Y Lam; Els Pardon; Konstantin V Korotkov; Wim G J Hol; Jan Steyaert
Journal:  J Struct Biol       Date:  2008-12-10       Impact factor: 2.867

7.  Camelid nanobodies raised against an integral membrane enzyme, nitric oxide reductase.

Authors:  Katja Conrath; Alice S Pereira; Carlos E Martins; Cristina G Timóteo; Pedro Tavares; Silvia Spinelli; Joerg Kinne; Christophe Flaudrops; Christian Cambillau; Serge Muyldermans; Isabel Moura; Jose J G Moura; Mariella Tegoni; Aline Desmyter
Journal:  Protein Sci       Date:  2009-03       Impact factor: 6.725

8.  Nanobody Conjugates for Targeted Cancer Therapy and Imaging.

Authors:  Wei Kang; Chuanfeng Ding; Danni Zheng; Xiao Ma; Lun Yi; Xinyi Tong; Chuang Wu; Chuang Xue; Yongsheng Yu; Qian Zhou
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

Review 9.  Single domain antibodies: promising experimental and therapeutic tools in infection and immunity.

Authors:  Janusz Wesolowski; Vanina Alzogaray; Jan Reyelt; Mandy Unger; Karla Juarez; Mariela Urrutia; Ana Cauerhff; Welbeck Danquah; Björn Rissiek; Felix Scheuplein; Nicole Schwarz; Sahil Adriouch; Olivier Boyer; Michel Seman; Alexei Licea; David V Serreze; Fernando A Goldbaum; Friedrich Haag; Friedrich Koch-Nolte
Journal:  Med Microbiol Immunol       Date:  2009-06-16       Impact factor: 3.402

10.  Llama antibody fragments with cross-subtype human immunodeficiency virus type 1 (HIV-1)-neutralizing properties and high affinity for HIV-1 gp120.

Authors:  Anna Forsman; Els Beirnaert; Marlén M I Aasa-Chapman; Bart Hoorelbeke; Karolin Hijazi; Willie Koh; Vanessa Tack; Agnieszka Szynol; Charles Kelly; Aine McKnight; Theo Verrips; Hans de Haard; Robin A Weiss
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.